期刊
JOURNAL OF NUTRITIONAL BIOCHEMISTRY
卷 89, 期 -, 页码 -出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jnutbio.2020.108556
关键词
L-theanine; prostate cancer; metastasis; MMP9; Snail
资金
- Natural Science Foundation of China [81671565, 81771703, 31571166]
- Priority Academic Program Development of Jiangsu Higher Education Institution (PADD)
L-theanine has been shown to inhibit invasion and migration of prostate cancer cells, as well as increase cell-cell adhesion. It also suppresses the epithelial-mesenchymal transition process in PCa. Through downregulating certain proteins and inhibiting specific signaling pathways, L-theanine shows therapeutic potential for metastatic prostate cancer.
Prostate cancer (PCa) is a very prevalent male-specific malignancy; most PCa patients eventually die as a result of metastasis. L-theanine (C7H14N2O3), a nonprotein amino acid derivative from green tea leaves, has been demonstrated to act as an anticarcinogen through proapoptotic and antiproliferative effects. However, the antimetastatic effect of L-theanine in tumor cells and its underlying mechanism are still unclear. Here, we found that L-theanine could suppress invasion, migration, and increase cell-cell adhesion of prostate cancer cells in vitro and in vivo . We also found that L-theanine could inhibit the epithelial-mesenchymal transition process in PCa. Our study revealed that L-theanine could downregulate MMP9, N-cadherin, Vimentin, Snail, and upregulate E-cadherin. Furthermore, L-theanine suppressed the transcription of MMP9 and Snail by significantly inhibiting the ERK/NF-KB signaling pathway and the binding activity of p65 to the promoter regions of MMP9 and Snail. All of these findings suggest that L-theanine has therapeutic potential for metastatic PCa and may be considered a promising candidate for antimetastatic therapy of prostate cancer. (c) 2020 Elsevier Inc. All rights reserved. Superscript/Subscript Available
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据